United Therapeutics Corporation

United Therapeutics Corporation is a biotechnology company focused on developing novel pharmaceutical therapies and technologies to treat chronic and life‑threatening conditions and to expand the availability of transplantable organs. Founded to address a rare disease, the company develops treatments for pulmonary arterial hypertension and other orphan and pulmonary diseases, and works on technologies related to organ transplantation and support for end‑stage organ disease. United Therapeutics is also notable for being the first publicly‑traded biotech or pharmaceutical company to adopt the public benefit corporation structure.